and can significantly reduce the burden of HPV-related genital warts and cancers among men, in addition to promoting herd immunity. Nevertheless, HPV4 coverage among boys remains low in most settings.
The future of HPV vaccination for boys and young men may be productively approached through an analysis of considerations and evidence at multiple levels that will advance policy and decision-making.
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration, providing a much-needed boost to the company in ...
Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a much-needed boost in a key market where demand has been falling among ...
The Human Papillomavirus also known as HPV is an ... more chronic diseases in men such as penile cancer. The impact of HPV in men is very rarely discussed but it can impact men just as much ...